Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adalimumab maintenance in Japanese Crohn's Disease
NCT00445432Phase 3Completed
- Sponsor
- Abbott Laboratories
- Start
- Mar 2007
- Primary completion
- Mar 2009
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 3 trial of adalimumab in Crohn's disease, sponsored by Abbott Laboratories. Started Mar 2007; status: completed.
02
Drugs
03
Conditions
Crohn's disease
Beyond the preview
Go deeper on NCT00445432.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00445432.